St. Jude Children's Research Hospital
480
96
150
268
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
8.8%
42 terminated/withdrawn out of 480 trials
86.5%
-0.1% vs industry average
5%
24 trials in Phase 3/4
32%
86 of 268 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (480)
Characterizing Sleep Among Long-term Survivors of Childhood Cancer
Role: lead
Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy
Role: lead
Response to Influenza Vaccination in Pediatric Oncology Patients
Role: lead
Culturally Adapted Mobile Treatment of Chronic Pain in Adolescent Survivors of Pediatric Cancer: A Randomized Clinical Trial
Role: lead
Feasibility of Incorporating a Standardized Substance Use Measure With Linked-Brief Intervention Into Routine Psychosocial Care of Adult Childhood Cancer Survivors
Role: lead
Light Therapy to Treat Depression in Pediatric Stem Cell Therapy Recipients
Role: lead
Cardiovascular Magnetic Resonance Prognosticators in Pediatric Oncology Patients With Sepsis
Role: lead
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
Role: lead
Feasibility of High Intensity Interval Training in Survivors of Childhood, Adolescent, and Young Adult Hodgkin Lymphoma
Role: lead
Investigation of the Genetics of Hematologic Diseases
Role: lead
Liver Biopsy Following Gene Therapy For Hemophilia
Role: lead
Resistance Exercise and Incretin Mimetic for Cardiometabolic Health in Survivors of ALL With Obesity
Role: lead
Sickle Cell Clinical Research and Intervention Program
Role: lead
Functional Ovarian Reserve in Sickle Cell Disease
Role: lead
A Phase II Study With a Safety Run-In of the Addition of N-803 to a Chemoimmunotherapy Backbone for the Treatment of Patients With Relapsed or Refractory Neuroblastoma
Role: lead
Deep Phenotyping Gait Deficits in Orthopedic Manifestations of Pediatric Cancer Patients
Role: lead
Outcomes of Health Care Transition for AYA With a Cancer Predisposition
Role: lead
Evaluation Of Cardiovascular Health Outcomes Among Survivors 2
Role: lead
TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies
Role: lead
SCD Stem Cell Mobilization and Apheresis Using Motixafortide
Role: lead